CN1291484A - Medicine for treating prostatic diseases - Google Patents

Medicine for treating prostatic diseases Download PDF

Info

Publication number
CN1291484A
CN1291484A CN 00122080 CN00122080A CN1291484A CN 1291484 A CN1291484 A CN 1291484A CN 00122080 CN00122080 CN 00122080 CN 00122080 A CN00122080 A CN 00122080A CN 1291484 A CN1291484 A CN 1291484A
Authority
CN
China
Prior art keywords
medicine
prostate
treating prostatic
present
prostatic diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 00122080
Other languages
Chinese (zh)
Inventor
周文山
孙慧康
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 00122080 priority Critical patent/CN1291484A/en
Publication of CN1291484A publication Critical patent/CN1291484A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A medicine for treating prostatic disease contains green chiretta, furantantin, metronidazole and vaseline. It is applied by leading it to prostate gland via anus. Its advantages is quick and high curative effect.

Description

The prostatic medicine of a kind of treatment
The present invention relates to the prostatic medicine of a kind of treatment.
At present the prostatic medicine of treatment has oral medicine such as Western medicine antibiotics and Chinese herbal medicine, also has methods such as operation in addition, but oral medicine absorbs through stomach, drains, and can arrive prostatic has been trace, the anti-inflammation poor effect, and course of treatment while is longer.Though the operation method therapeutic effect is better, because the improper injured thing of other function of involving of operation on prostate also has generation by chance.China Patent No. 93104714 discloses a kind of " Chinese medicinal ointment and the usings method of treatment prostatitis, pelvic infection mastitis ", and it is to adopt Radix Sophorae Flavescentis, Radix Gentianae, Rhizoma Smilacis Glabrae, and Chinese herbal medicine formulas such as the Radix Angelicae Dahuricae are made, and utilize skin to inhale medicine and reach inner disease outer treat.Though it is more effective than for oral administration to utilize skin to inhale medicine, but can not accomplish the active ingredient that fully absorbs the drug.
The object of the present invention is to provide and a kind ofly directly send into the medicine that prostate can fully be absorbed by prostate by anus.
The objective of the invention is to make by weight by following prescription:
Herba Andrographis 2-7
Nitrofurantoin 1-5
Metronidazole 2-6
Vaseline 3-8
The present invention treats the medicine for prostate disease production technology for above-mentioned patent medicine is processed into tablet, unguentum, powder.
The present invention treats that each composition pharmacological property is in the medicine for prostate disease prescription:
Herba Andrographis: cold in nature, heat clearing away, removing heat from blood, scattered inflammatory swelling, contain multiple lactone and steroid class, good broad-spectrum antibacterial action is arranged, toxicity is little.
Nitrofurantoin: for oral administration have certain side effect, makes the solvent external more, and broad-spectrum antibacterial action is arranged.
Metronidazole: the anaerobe resistant effect is arranged, infusorian and ameba are had very strong sterilization functions.
Medicinal vaseline: being carrier, is again the lubricant of anal canal simultaneously, and it can slow down the absorption of medicine, prolongs drug effect, reduces the medication number of times, and can be made into tablet or enteric solubility colloid, absorb faster, better effects if.Owing near prostate and the anal sinus, often, use recurrence due to taking drug such as metronidazole and nitrofurantoin to close use, can reach the diligent of Synergistic because of the remaining bacterium pearl intrusion that causes of defecating.
The present invention treats the using method of prostate special-purpose medicaments for directly sending into the prostate body of gland by anus, and every day 1-2 time, medication preferably is selected in greatly after an action of the bowels, and anus is cleaned, and sends into tablet behind the lubricated anus.The present invention treats medicine for prostate disease to have medicine and can fully be inhaled and receive curative effect characteristics faster by prostate.
Below in conjunction with concrete case and embodiment the present invention is further described.
The prescription of a specific embodiment of the present invention is as follows, and consumption is a weight portion:
2 parts of Herba Andrographis
3 parts of nitrofurantoins
2 parts of metronidazoles
3 parts of medicinal vaselines
Case: Zhou Yi: the veteran cadre of Jiangxi Province transportation department, 65 years old age, suffer from prostatosis for many years, not good enough through the western medicines in treatment effect, get well very soon behind the above-mentioned specific embodiment formula for treating of the use the present invention medicine for prostate disease.

Claims (1)

1, the prostatic medicine of a kind of treatment is characterized in that being made by following prescription, and consumption is a weight portion:
Herba Andrographis 2-7
Nitrofurantoin 1-5
Metronidazole 2-6
Vaseline 3-8
CN 00122080 2000-08-18 2000-08-18 Medicine for treating prostatic diseases Pending CN1291484A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 00122080 CN1291484A (en) 2000-08-18 2000-08-18 Medicine for treating prostatic diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 00122080 CN1291484A (en) 2000-08-18 2000-08-18 Medicine for treating prostatic diseases

Publications (1)

Publication Number Publication Date
CN1291484A true CN1291484A (en) 2001-04-18

Family

ID=4589077

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 00122080 Pending CN1291484A (en) 2000-08-18 2000-08-18 Medicine for treating prostatic diseases

Country Status (1)

Country Link
CN (1) CN1291484A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9655883B2 (en) 2002-08-26 2017-05-23 Sla Pharma Ag Pharmaceutical composition

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9655883B2 (en) 2002-08-26 2017-05-23 Sla Pharma Ag Pharmaceutical composition
US10653671B2 (en) 2002-08-26 2020-05-19 S.L.A. Pharma, Ag Topical pharmaceutical compositions for treatment of skin damage
US10709689B2 (en) 2002-08-26 2020-07-14 Sla Pharma Ag Pharmaceutical composition
US10881640B2 (en) 2002-08-26 2021-01-05 S.L.A. Pharma Ag Topical pharmaceutical compositions for treatment of pilonidal sinus wounds

Similar Documents

Publication Publication Date Title
CN1883618B (en) Effective parts of cirald daphne bark, preparation method and application thereof
CN101549016A (en) Traditional Chinese medicine composition for treating acute and chronic pharyngitis and preparation method thereof
CN103432497B (en) External preparation for treating haemorrhoids
CN1319582C (en) Chinese medicine solution agent for treating damp-heat disease and its preparing method
CN1291484A (en) Medicine for treating prostatic diseases
CN102579528B (en) Medicine composition for preventing and curing prostatic diseases
CN102210744A (en) Anti-virus infection traditional Chinese medicine composition
CN1235608C (en) Medicine for curing prostatosis and its preparation method
CN1141966C (en) Stone expelling medicine powder
CN101623411A (en) Chinese medicament for resisting bacteria and diminishing inflammation, clearing away heat and toxic material, and removing blood stasis and relieving pain
CN103908558A (en) Traditional Chinese medicine composition for treating acne and preparation method and application thereof
CN105963551B (en) Prescription for treating skin diseases
CN100360163C (en) Externally-applied Chinese medicine for treating acute and chronic pharyngolaryn gitis and its therapeutic belt thereof
CN103599281B (en) Traditional Chinese medicinal composition for treating obsessive-compulsive disorder and application thereof
CN101618118B (en) Application of Chinese medicinal composition in preparing medicament for treating cystitis
CN100394967C (en) Chinese medicine composition for treating wrinary tract disease
CN1507880A (en) Medicinal composition for treating rheumatoid
CN1273155C (en) Oral Chinese medicinal preparation for treating acute pharyngolaryngitis
CN1248697C (en) Medicinal composition for treating chronic enteritis and its preparing process
CN1286989A (en) Suppository for treating cervical erosion and vaginitis
CN1146904A (en) Antibacterial herb medicine tablet
CN1814148A (en) Chinese medicine composition for treating prostatitis and use thereof
CN103751314A (en) Traditional Chinese medicine formula preparation for treating toothache and preparation method thereof
CN115844956A (en) Traditional Chinese medicine fermented hydrogel for quickly healing and treating gynecological inflammation
CN104491462A (en) Medicine composition used for treating burns and scalds

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication